<?xml version="1.0" encoding="UTF-8"?>
<p>Being the first step in the infection process, the entry of pathogenic viruses into susceptible cells is an extremely attractive intervention point. As with other well-known viruses, such as HIV-1 and Ebola, viral entry of coronaviruses is a complex multiple-step process with numerous interactions and processing points that, in theory, could be targeted.
 <sup>
  <xref ref-type="bibr" rid="ref33">33</xref>
 </sup> In this review, we summarize case studies and highlight efforts in designing entry inhibitors against SARS-CoV, MERS-CoV, and other coronaviruses that can provide important information to combat the current SARS-CoV-2 outbreak.
</p>
